WILLIAMS KRISTEN — SEC insider filings
SEC reporting owner CIK 1296965. 22 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2020-09-17 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 30 legs across 17 filings — 214,938 shares, $11,454,391 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 85.
- Largest priced transaction: sale of 23,040 shares @ $65.24 ($1,503,130) in Pacira BioSciences, Inc., filed 2022-01-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | Chief Administrative Officer | 22 | — | 30 legs · 214,938 sh · $11,454,391 | 85 |
Insider filings — WILLIAMS KRISTEN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Pacira BioSciences, Inc. (PCRX) | Disposition to issuer (D): 167,062 @ $36.50 · Disposition to issuer (D): 2,953 (derivative) · Disposition to issuer (D): 10,560 (derivative) · Disposition to issuer (D): 19,685 (derivative) · Disposition to issuer (D): 17,500 (derivative) · Disposition to issuer (D): 24,800 (derivative) · +1 more | EDGAR |
| 2026-06-05 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 8,528 @ $22.32 · Sale (S): 10,259 @ $22.27 | EDGAR |
| 2026-02-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 54,546 @ $0 | EDGAR |
| 2026-02-03 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 17,134 @ $20.54 · Sale (S): 13,137 @ $20.53 | EDGAR |
| 2025-06-05 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 6,162 @ $26.40 · Sale (S): 14,376 @ $26.24 | EDGAR |
| 2025-02-04 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 79,200 @ $0 | EDGAR |
| 2024-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 54,300 @ $0 · Sale (S): 7,452 @ $28.38 | EDGAR |
| 2024-06-05 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 3,011 @ $30.89 | EDGAR |
| 2024-02-07 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 33,700 @ $0 | EDGAR |
| 2023-06-16 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 10,950 @ $0 · Sale (S): 6,467 @ $37.03 · Grant/award (A): 27,500 (derivative) @ $0 | EDGAR |
| 2023-06-07 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 1,301 @ $38.99 · Sale (S): 1,357 @ $37.87 | EDGAR |
| 2022-06-08 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 3,969 @ $61.37 · Sale (S): 4,649 @ $59.51 · Grant/award (A): 9,900 @ $0 · Grant/award (A): 24,800 (derivative) @ $0 | EDGAR |
| 2022-03-23 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 2,953 @ $38.35 · Option exercise (M): 2,112 @ $43.54 · Option exercise (M): 2,188 @ $47.65 · Sale (S): 7,253 @ $72.67 · Option exercise (M): 2,953 (derivative) @ $0 · Option exercise (M): 2,112 (derivative) @ $0 · +1 more | EDGAR |
| 2022-03-01 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 10 @ $38.35 · Sale (S): 10 @ $65 · Option exercise (M): 2,050 @ $38.35 · Sale (S): 50 @ $65 · Sale (S): 2,000 @ $67.07 · Option exercise (M): 10 (derivative) @ $0 · +1 more | EDGAR |
| 2022-02-14 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 800 @ $38.35 · Sale (S): 800 @ $65.18 · Option exercise (M): 800 (derivative) @ $0 | EDGAR |
| 2022-02-08 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 1,000 @ $38.35 · Sale (S): 1,000 @ $65.18 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2022-01-25 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 200 @ $38.35 · Sale (S): 200 @ $65.41 · Option exercise (M): 200 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 1,375 @ $44.20 · Option exercise (M): 2,600 @ $38.35 · Option exercise (M): 6,338 @ $43.54 · Option exercise (M): 13,127 @ $47.65 · Sale (S): 23,040 @ $65.24 · Sale (S): 400 @ $66.14 · +7 more | EDGAR |
| 2021-06-11 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 7,000 @ $0 · Sale (S): 4,842 @ $59.43 · Sale (S): 847 @ $60.57 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2021-06-08 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 3,930 @ $61.04 | EDGAR |
| 2021-04-15 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 2,500 @ $32.35 · Option exercise (M): 4,125 @ $44.20 · Option exercise (M): 8,859 @ $38.35 · Option exercise (M): 6,339 @ $43.54 · Sale (S): 14,793 @ $66.40 · Sale (S): 7,030 @ $68.11 · +4 more | EDGAR |
| 2020-09-17 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 5,832 @ $40.34 · Option exercise (M): 5,832 @ $32.35 · Option exercise (M): 5,499 @ $44.20 · Option exercise (M): 7,874 @ $38.35 · Option exercise (M): 2,816 @ $43.54 · Sale (S): 14,622 @ $59.01 · +30 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1296965 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs